Key Takeaways
- EBITDA improved despite a large-client headwind: EBITDA margin rose 70 bps QoQ (160 bps gross, offset by 90 bps from wage hikes), driven by utilization gains, offshoring, and AI-led productivity, even as the largest BFSI client ramped down significantly.
- AI order book doubled its share: AI deals grew from 8% to 10% of the order book, with TMT verticals showing the highest adoption, while the new AgentBridge platform and AI CSP co-sell programs aim to build a sustainable new-client engine.
- Vertical mix transformation continues: Healthcare & Life Sciences and BFSI now contribute 33% of revenue, up from 13% three years ago, and management targets scaling these to $250 million in three to five years.
- Client concentration is easing, but one BFSI client still hurts: Top-10 client revenue share fell from 56% to 53%, yet the largest BFSI account’s ramp-down will bleed into Q3 before full absorption; outside that account, banking and healthcare momentum is solid.
- What to watch next quarter: Whether the BFSI large-client impact is fully absorbed by Q3-end as promised, whether TMT budget dissemination unlocks new business by Q4, and whether the SITL business can return toward its 15% gross-contribution CAGR aspiration.
Demand Environment & Vertical Performance
- BFSI: one large drag, broad strength underneath. The largest BFSI client underwent organizational changes and budget constraints, causing a significant ramp-down that will see final impact in Q3. Outside that account, banking and healthcare together constitute about 60% of total outsourcing, an area Sonata did not have three years ago, and many accounts have potential to scale to top-tier clients.
- TMT: two tales. Big tech is soft due to one large client where re-organization has delayed budget dissemination; outside big tech, small and medium tech has seen very strong growth, and the large deal announced earlier this year was in TMT. Renewals happened as expected with no shrinkage; the challenge is winning new business until budgets are disseminated, expected by January.
- Healthcare & Life Sciences: scaling fast. Won a large deal with a leading US healthcare provider for multi-year core platform modernization, plus two AI CSP mid-sized deals with a healthcare client. The vertical is on track toward the $250 million target alongside BFSI.
- Retail & Manufacturing: muted, with a one-time aberration. Retail manufacturing has been muted given tariff-side issues; this quarter included one-time revenue, making it an aberration. Management expects stabilization and a return to growth in the next 2-3 quarters, hopefully by Q1 next year.
- North America dominance deepens. North America now over 70% of revenue, up from approximately 54% three years ago, reflecting the success of the vertical strategy in the region.
Samir Dhir: "Once the whole impact of this one large client is absorbed, I think it will be fully absorbed at the end of Q3, then I think we'll be looking to build a business from there further on going into Q4."
Margin Walk & Operational Efficiency
- Utilization rose to 87.3% from 86.6%, and management expects further improvement from AI-driven productivity gains across all functions.
- Offshoring mix improved to 57% from 53%, driven by planned offshoring from large deals won over several quarters; this is considered a sustainable structural shift, not a one-time move.
- AI and agentic AI are now deployed internally across HR and Finance functions, contributing to the 160 bps gross margin expansion before wage hikes. Management calls this a systematic, sustainable model.
- Wage hikes took 90 bps in Q2, and Q3 will see a similar impact; management believes it can absorb this and remain EBITDA accretive.
- PAT accretion expected in H2 versus H1, as the full-quarter upside from Q2’s sustainable actions flows into Q3.
Samir Dhir: "We've always talked about our aspiration to be a high-teens EBITDA company and aspiration to be a low-teens, low-20s EBITDA company. So we're well on our path to be a high-teens EBITDA company at this point in time."
SITL Business: Headwinds & Diversification
- Microsoft policy change created headwinds, but a three-pillar strategy enacted 4-6 quarters back is balancing them out: expanding the Microsoft channel with an SMC focus, broadening partnerships with other ISVs (Oracle, IBM, OpenText), and winning large SI deals.
- Gross contribution, not revenue, is the focus metric in SITL; there is not always a direct correlation between profit and revenue, and the group concentrates on maintaining and growing GC.
- Microsoft direct billing uncertainty: Microsoft is doing direct billing for the first time in Asia-Pacific including India, and may decide to go direct with 10-15 accounts. Management expects no customers to transition in the next six months, and even if Microsoft decides to go direct, they wait for the renewal period.
- The 15% CAGR gross-contribution aspiration discussed earlier is under pressure; management is trying to come back to that growth in the next few quarters but gave no explicit confirmation or revision of the target.
Sujit Mohanty: "As of now, there is nothing in writing from Microsoft that what they're going to do and how they're going to do... Based on our understanding and how it has happened in other countries... there will be some accounts, some customers which they may decide to go direct."
AI & Platform Strategy
- AgentBridge platform launched earlier this year as a cloud-agnostic agentic platform; collaborations with IISC in India and the Wharton School in the US support enhanced research in agentic AI. The platform won CII AI Awards 2025 for Best AI Solution Showcase and Best Industry AI Application.
- AI CSP co-sell program replicates Microsoft’s new AI consumption model with other CSPs; management expects AI and CSP deals to drive both client expansion and sustainable new-client acquisition engines.
- Mid-sized AI wins span verticals: a financial mortgage leader migrating legacy apps, a US consumer product client building an enterprise AI playground, and two AI CSP deals with a healthcare client and a global TMT client.
- Internal deployment as proof: HR and Finance teams now run production-grade agents, reinforcing the aspiration to be a model AI-led technology services firm.
Samir Dhir: "We want to be a differentiated AI modernization engineering firm powered by a proprietary platformation framework."
People, Costs & Client Metrics
- Headcount declined from 6,859 to 6,649, with attrition at 14%; the annual compensation revision is proceeding despite market headwinds, enacted in Q2 and continuing in Q3.
- Top-10 client concentration fell from 56% to 53%, a positive diversification signal even as the largest BFSI client ramped down.
- A new sales leader joined: Inder Samath took over as Sales Leader for Quant, replacing Srini who left the company.
- Quarterly interim dividend policy was introduced; the company declared a second interim dividend of ₹1.25 per share and intends to follow this payout pattern going forward.
- Cloud and data opportunities now represent 55% of the total pipeline, reflecting strong client demand for modernization.
Samir Dhir: "We are proceeding with our annual compensation revision for this year, despite market headwinds."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| BFSI large-client impact absorption | Largest BFSI client ramp-down fully absorbed | End of Q3 FY26 |
| BFSI momentum build | Momentum to build from Q4 onwards in banking | Q4 FY26 onwards |
| TMT budget dissemination | Budgets expected to be disseminated; uptake to start | By January; Q4 FY26 or worst case Q1 FY27 |
| Q3 wage hike impact | Impact expected in same range as Q2 (90 bps); management believes it can absorb and remain EBITDA accretive | Q3 FY26 |
| Retail & Manufacturing recovery | Stabilization and return to growth | Next 2-3 quarters, hopefully by Q1 FY27 |
| Healthcare & BFSI vertical scale | Scale to $250 million of revenue | Three to five years |
| Microsoft direct billing transitions | No customers expected to go direct with Microsoft | Next six months |
| EBITDA aspiration | High-teens EBITDA company | No date; "well on our path" |
Key Metrics
| Metric | Q2 FY26 |
|---|---|
| Consolidated revenue | ₹2,119.3 cr, degrowth of 28.5% QoQ and 2.3% YoY |
| International Services revenue | ₹730.30 cr, +4.3% QoQ and +3.2% YoY; USD revenue $82 million, +0.2% QoQ, +1% QoQ constant currency |
| Domestic business revenue | ₹1,391.3 cr, degrowth of 38.8% QoQ and 4.8% YoY |
| International Services EBITDA before other income and forex | 17.3%, up 70 bps QoQ from 16.6%; wage hike impact of 90 bps absorbed |
| International Services EBITDA after other income and forex | 19.9%, up 150 bps QoQ from 18.4% |
| Consolidated PAT | ₹120.2 cr, +10% QoQ and +12.9% YoY |
| Consolidated EPS | ₹4.33 per share, +9.9% QoQ from ₹3.94 |
| International Services PAT | ₹78 cr, +10.3% QoQ and +25.5% YoY |
| Order book | $105 million, book-to-bill ratio of 1.28 |
| AI order book share | 10% of total order book, up from 8% in Q1 |
| Large deal wins | 1 large deal won in the quarter (Healthcare) |
| Utilization (International Services) | 87.3%, up from 86.6% in Q1 |
| Offshore revenue mix | 57%, up from 53% in Q1 |
| Trailing 12-month attrition | 14% |
| Total headcount | 6,649, down from 6,859 in Q1 |
| Clients with >$10 million annualized run rate | 8 |
| New enterprise clients added | 6 |
| Cash and cash equivalents | ₹323 cr, compared to ₹600 cr in Q1 |
| Dividend declared | ₹1.25 per share, second interim dividend |